The library will be closed between August 10, 2026 and August 16, 2026. During this period, it will be possible to upload publications, but all other services will be suspended.
Jambrovics, K.,
Póliska, S.,
Scholtz, B.,
Uray, I. P.,
Balajthy, Z.:
ATO Increases ROS Production and Apoptosis of Cells by Enhancing Calpain-Mediated Degradation of the Cancer Survival Protein TG2.
Int. J. Mol. Sci. 24 (13), 1-11, (article identifier: 10938), 2023.
Jambrovics, K.,
Balajthy, Z.:
ATRA and ATO combination has several beneficial effects in treatment of Acute Promyelocytic Leukaemia cells.
In: 15th Molecular, Cell and Immune Biology Winter Symposium : Book of abstract, University of Debrecen, Debrecen, 25, 2022.
Jambrovics, K.,
Uray, I. P.,
Keillor, J. W.,
Fésüs, L.,
Balajthy, Z.:
Benefits of Combined All-Trans Retinoic Acid and Arsenic Trioxide Treatment of Acute Promyelocytic Leukemia Cells and Further Enhancement by Inhibition of Atypically Expressed Transglutaminase 2.
Cancers (Basel). 12 (3), 648-, (article identifier: 648), 2020.
Jambrovics, K.,
Uray, I. P.,
Keresztessy, Z.,
Keillor, J. W.,
Fésüs, L.,
Balajthy, Z.:
Transglutaminase 2 programs differentiating acute promyelocytic leukemia cells in all-trans retinoic acid treatment to inflammatory stage through NF-kB activation.
Haematol-Hematol. J. 104 (3), 505-515, 2019.
Csomós, K.,
Német, I.,
Fésüs, L.,
Balajthy, Z.:
Tissue transglutaminase contributes to the all-trans retinoic acid induced differentiation syndrome phenotype in the NB4 model of acute promyelocytic leukemia.
Blood. 116 (19), 3933-3943, 2010.
Széles, L.,
Keresztes, G.,
Töröcsik, D.,
Balajthy, Z.,
Krenács, L.,
Póliska, S.,
Steinmeyer, A.,
Zuegel, U.,
Pruenster, M.,
Rot, A.,
Nagy, L.:
1,25 dihidroxyvitamin D3 Is an autonomous regulator of the transcriptional changes leading to a tolerogenic dendritic cell phenotype.
J. Immunol. 182 (4), 2047-2083, 2009.